Living beyond childhood cancer and its treatments
This year, for Childhood Cancer Awareness Month (CCAM), CCLG has been working hard to raise awareness of the long-term impact of childhood cancer and its treatments.
This year, for Childhood Cancer Awareness Month (CCAM), CCLG has been working hard to raise awareness of the long-term impact of childhood cancer and its treatments.
Sarah Davis' daughter Emma was diagnosed with acute lymphoblastic leukaemia (ALL) as a 12-year-old. She writes about the support the family received and the progress Emma has made since finishing treatment
First formed to establish clinical trials in childhood cancer, research has always been an integral part of CCLG’s work. Ellie Ellicott, CCLG Research Communications Executive, tells us more about its research journey and how the experiences of those that matter the most are helping shape future directions.
Naomi Shefford-Thomas, CCLG's Health Information Officer, discusses the importance of accessible information, how it works, and the steps CCLG is taking to make its health resources more inclusive and available to everyone.
Nicky Levent’s son, Sam, was diagnosed with retinoblastoma when he was 18 months old. She explains what it means to her family to raise funds for charities and awareness of childhood cancer, and how it’s helped them.
Child Cancer Smart is a public health intervention aiming to empower both the public and healthcare professionals with knowledge about childhood cancer symptoms. Dr Shaarna Shanmugavadivel, CCLG Research Fellow at the University of Nottingham and part of the project team, tells us more.
Lead investigator Susie Aldiss, a research fellow at the University of Surrey, discusses her research, which is funded by a £92,000 award from CCLG.
Louise Graham is a clinical specialist paediatric physiotherapist at The Great North Children’s Hospital. She tells us about how she created a physical activity pathway to help children and young people (CYP) with acute lymphoblastic leukaemia (ALL) stay active, and how she hopes to develop this to support all CYP with cancer.
Dr Claudia Heggie is a paediatric dentist at the University of Leeds and Leeds Teaching Hospitals Trust. She’s been leading research looking at the use of photobiomodulation, a light treatment, to prevent a side effect of chemotherapy called mucositis, and how it can be best introduced in other children’s cancer centres.